Risedronate
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Risedronate and local guidelines before prescribing.
Bisphosphonate
Mechanism
Oral bisphosphonate.
Uses
Osteoporosis, Paget disease.
Dosing
- Treat bone pain from active Paget's with a bisphosphonate. Zoledronic acid 5 mg IV as a single infusion is most effective, often giving years of remission. Ensure vitamin D is replete beforehand. Alternatives are oral risedronate or alendronate.
Endocrinology: Bone Medicine - Risedronate (osteoporosis) | 35 mg orally once weekly. Same administration rules. An alternative if alendronate is not tolerated.
Endocrinology: Bone Medicine
Side effects
Dyspepsia, oesophagitis, hypocalcaemia, atypical fracture.
Interactions
Calcium and antacids reduce absorption.
Contraindications and cautions
Oesophageal disease, hypocalcaemia, eGFR below 30
Monitoring
Calcium, vitamin D
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid if eGFR below 30
Overdose and reversal
Supportive; milk or antacid
Special advice
Take upright 30 minutes before food with water.
More from the textbook: uses, cautions and other points
- High risk: Oral bisphosphonate (alendronic acid or risedronate) first-line. If not tolerated, unsuitable or ineffective: IV zoledronic acid or denosumab. HRT is an option in younger postmenopausal women.
Endocrinology: Bone Medicine - First-line: An oral bisphosphonate (alendronate or risedronate), plus adequate calcium and vitamin D.
Endocrinology: Bone Medicine - Treatment: Alendronate, risedronate, zoledronic acid, denosumab (licensed in men, including on androgen deprivation), or teriparatide. Testosterone replacement for hypogonadism, unless contraindicated.
Endocrinology: Bone Medicine - Bisphosphonates — alendronic acid (weekly), risedronate, IV zoledronic acid (yearly) | Bind hydroxyapatite; taken up by osteoclasts → inhibit farnesyl pyrophosphate synthase → osteoclast apoptosis — anti-resorptive | Oral — take fasting with a full glass of water, sit upright 30 minutes ( oesophagitis ); avoid if eGFR under 35; IV — …
Rheumatology Anatomy Physiology Pharmacology - Oral bisphosphonates (alendronic acid weekly, risedronate) - first line; take upright, with water, 30 minutes before food ; avoid in eGFR under 35; check vitamin D and calcium first; review at 5 years (drug holiday for some).
Medicine of the older adult.: Falls, syncope, mobility and fragility fractures